Table 1 |
||||||
|
Extracellular space genes regulated at least 1.45-fold by TNFαa |
||||||
| Gene |
Accession number |
Description |
Fold change |
Basal MEK/ERK dependent |
||
|
|
||||||
| U0126 |
TNF |
TNF + U0126 |
||||
|
|
||||||
| TNFα-regulated MEK/ERK dependent |
||||||
| Hyaluronic acid binding activity |
||||||
| Agc1 |
[GenBank:NM_022190] |
Aggrecan 1 |
1.14 |
0.68 |
1.08 |
|
| Hapln1 |
[GenBank:NM_019189] |
Hyaluronan and proteoglycan link protein 1 |
1.15 |
0.65 |
0.96 |
|
| Collagenase or metallopeptidase activity |
||||||
| Mmp-12 |
[GenBank:NM_053963] |
Matrix metallopeptidase 12 |
0.67 |
2.92 |
0.93 |
|
| Mmp-9 |
[GenBank:NM_031055] |
Matrix metallopeptidase 9 |
0.87 |
1.89 |
1.01 |
|
| Metallopeptidase activity |
||||||
| Arts1, ERAP1, Appils |
[GenBank:NM_030836] |
Type 1 TNF receptor shedding aminopeptidase regulator |
1.33 |
1.78 |
1.55 |
|
| Complement binding |
||||||
| C4bpa |
[GenBank:NM_012516] |
Complement component 4 binding protein, alpha |
1.01 |
2.19 |
1.35 |
|
| Others |
||||||
| Amigo2 |
[GenBank:NM_182816] |
Adhesion molecule with Ig-like domain 2 |
0.99 |
1.55 |
1.26 |
|
| Cacna2d3 |
[GenBank:NM_175595] |
Calcium channel, voltage-dependent, α2/δ3 subunit |
0.82 |
1.56 |
0.99 |
|
| Cd68 (predicted) |
[GenBank:NM_001031638] |
CD68 antigen |
1.01 |
1.80 |
1.14 |
|
| Cgref1, Cgr11 |
[GenBank:NM_139087] |
Cell growth regulator with EF hand domain 1 |
1.01 |
0.61 |
0.83 |
|
| Cyp4b1 |
[GenBank:NM_016999] |
Cytochrome P450, family 4, subfamily b, polypeptide 1 |
1.71 |
1.72 |
1.83 |
|
| Gm1960, Cinc2, Cinc-2 |
[GenBank:NM_138522] |
Gene model 1960 (NCBI) |
0.94 |
2.38 |
1.27 |
|
| TNFα-regulated MEK/ERK independent |
||||||
| Peptidase activity |
||||||
| Adam17; TACE |
[GenBank:NM_020306] |
A disintegrin and metalloproteinase domain 17 (TNF, alpha, converting enzyme) |
0.93 |
1.64 |
1.41 |
|
| Mmp13 |
[GenBank:XM_343345] |
Matrix metallopeptidase 13 |
0.33 |
6.80 |
1.10 |
* |
| Ctsc |
[GenBank:NM_017097] |
Cathepsin C |
1.18 |
2.84 |
1.72 |
|
| Serpinb2, Pai2a |
[GenBank:NM_021696] |
Serine (or cysteine) proteinase inhibitor, clade B, member 2 |
0.75 |
3.47 |
1.68 |
|
| Plat, tPA, PATISS |
[GenBank:NM_013151] |
Plasminogen activator, tissue |
0.94 |
3.22 |
1.56 |
|
| Plau, UPAM |
[GenBank:NM_013085] |
Plasminogen activator, urokinase |
1.36 |
2.23 |
2.87 |
|
| C1s, r-gsp |
[GenBank:NM_138900], [GenBank:XM_575664] |
Complement component 1, s subcomponent |
1.05 |
1.98 |
1.88 |
|
| Cpxm1 (predicted) |
[GenBank:XM_215840] |
Carboxypeptidase × 1 (M14 family) (predicted) |
1.21 |
3.11 |
1.84 |
|
| Mmp3 |
[GenBank:NM_133523] |
Matrix metallopeptidase 3 |
0.36 |
10.26 |
3.41 |
* |
| Chemokine activity |
||||||
| Ccl5, Scya5, Rantes |
[GenBank:NM_031116] |
Chemokine (C-C motif) ligand 5 |
0.90 |
4.26 |
1.37 |
|
| Cxcl12, Sdf1 |
[GenBank:NM_001033882], [GenBank:NM_001033883], [GenBank:NM_022177] |
Chemokine (C-X-C motif) ligand 12 |
0.75 |
2.17 |
1.33 |
|
| Ccl20, ST38, Scya20 |
[GenBank:NM_019233] |
Chemokine (C-C motif) ligand 20 |
0.65 |
12.86 |
5.82 |
|
| Cx3cl1, Cx3c, Scyd1 |
[GenBank:NM_134455] |
Chemokine (C-X3-C motif) ligand 1 |
0.72 |
4.41 |
2.95 |
|
| Cxcl1, Gro1, CINC-1 |
[GenBank:NM_030845] |
Chemokine (C-X-C motif) ligand 1 |
0.55 |
9.18 |
3.61 |
* |
| Cxcl10, IP-10, Scyb10 |
[GenBank:NM_139089] |
Chemokine (C-X-C motif) ligand 10 |
0.88 |
2.40 |
3.22 |
|
| Ccl2, MCP-1, Scya2, Sigje |
[GenBank:NM_031530] |
Chemokine (C-C motif) ligand 2 |
0.68 |
32.14 |
22.59 |
|
| Cytokine or growth factor activity |
||||||
| Bmp2 |
[GenBank:NM_017178] |
Bone morphogenetic protein 2 |
0.89 |
1.61 |
1.53 |
|
| Gdf10 |
[GenBank:NM_024375] |
Growth differentiation factor 10 |
0.59 |
0.30 |
0.21 |
* |
| Csf1 |
[GenBank:NM_023981] |
Macrophage colony-stimulating factor 1 |
0.86 |
2.37 |
2.17 |
|
| Ifngr1 |
[GenBank:NM_053783] |
IFNγ receptor 1 |
0.96 |
1.97 |
1.39 |
|
| Spp1, OSP |
[GenBank:NM_012881] |
Secreted phosphoprotein 1 |
0.97 |
4.21 |
1.98 |
|
| Vegfa |
[GenBank:NM_031836] |
Vascular endothelial growth factor A |
1.11 |
1.80 |
1.43 |
|
| ATPase activity |
||||||
| Tap1, Cim, Abcb2 |
[GenBank:NM_032055] |
Transporter 1, ATP-binding cassette, subfamily B (MDR/TAP) |
1.22 |
1.91 |
2.24 |
|
| Tap2, Cim, Abcb3 |
[GenBank:NM_032056] |
Transporter 2, ATP-binding cassette, subfamily B (MDR/TAP) |
1.01 |
2.11 |
1.91 |
|
| G-protein coupled receptor binding |
||||||
| Ramp1 |
[GenBank:NM_031645] |
Receptor (calcitonin) activity modifying protein 1 |
2.16 |
0.53 |
0.93 |
|
| Ramp2 |
[GenBank:NM_031646] |
Receptor (calcitonin) activity modifying protein 2 |
0.88 |
1.57 |
1.31 |
|
|
|
||||||
|
aGenes separated into molecular function subcategories represented in the list of gene changing at least 1.45-fold by TNFα as either mitogen-activated kinase kinase (MEK)/extracellular regulated kinase (ERK) dependent or MEK/ERK independent. Specifically defined subcategories were identified in the molecular function gene ontology as significantly represented (P < 0.01) within the MEK/ERK dependent or MEK/ERK independent lists. |
||||||
|
Rockel et al. Arthritis Research & Therapy 2009 11:R8 doi:10.1186/ar2595 |
||||||